# Validation of Predictors of OAC Initiation Using EMR Data

> **NCT03006341** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 140187 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dabigatran etexilate
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03006341
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-28
- **Primary completion:** 2017-05-09
- **Final completion:** 2017-05-09
- **Target enrollment:** 140187 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006341, "Validation of Predictors of OAC Initiation Using EMR Data". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03006341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*